HB 86 Summary

• Amends Idaho Code Section 37-2705 to revise Schedule I controlled substances by distinguishing tetrahydrocannabinols (THCs) from synthetic cannabinoid drugs that mimic cannabis effects.

• Specifically excludes dronabinol in sesame oil encapsulated in soft gelatin capsules when approved by the U.S. Food and Drug Administration from Schedule I classification.

• Adds synthetic drugs structurally derived from various chemical compounds (indole, pyrrole, indene, phenylacetyl, and benzoyl structures) that produce cannabis-like effects to Schedule I, with specific substitution patterns listed.

• Adds new stimulant substances to Schedule I including aminorex, cathinone, methcathinone, N-benzylpiperazine, N-ethylamphetamine, and N,N-dimethylamphetamine.

• Declares emergency status, making the act effective upon passage and approval.